TY - JOUR
T1 - Long-term impact of immunosuppressants at therapeutic doses on male reproductive system in unilateral nephrectomized rats
T2 - A comparative study
AU - Chen, Yehui
AU - Zhang, Zhi
AU - Lin, Yun
AU - Lin, Huaxin
AU - Li, Miaoyuan
AU - Nie, Pin
AU - Chen, Lizhong
AU - Qiu, Jiang
AU - Lu, Yanmeng
AU - Chen, Linqiang
AU - Xu, Banglao
AU - Lin, Wuzhou
AU - Zhang, Jing
AU - Du, Hong
AU - Liang, Jianjian
AU - Zhang, Zhiwei
PY - 2013
Y1 - 2013
N2 - Cyclosporine, tacrolimus, and sirolimus are commonly used in renal transplant recipients to prevent rejection. However, information for comparative effects of these agents on the male productive system is extremely limited and controversial. In a physiologically and clinically relevant rat model of unilateral nephrectomy, we demonstrated that long-term oral administration of both cyclosporine and sirolimus at doses equivalent to the therapeutic levels used for postrenal transplant patients significantly affects testicular development and the hypothalamic-pituitary-gonadal axis accompanied by profound histological changes of testicular structures on both light and electron microscopic examinations. Spermatogenesis was also severely impaired as indicated by low total sperm counts along with reduction of sperm motility and increase in sperm abnormality after treatment with these agents, which may lead to male infertility. On the other hand, treatment with therapeutic dose of tacrolimus only induced mild reduction of sperm count without histological evidence of testicular injury. The current study clearly demonstrates that commonly used immunosuppressants have various impacts on male reproductive system even at therapeutic levels. Our data provide useful information for the assessment of male infertility in renal transplant recipients who wish to father children. Clinical trials to address these issues should be urged. © 2013 Yehui Chen et al.
AB - Cyclosporine, tacrolimus, and sirolimus are commonly used in renal transplant recipients to prevent rejection. However, information for comparative effects of these agents on the male productive system is extremely limited and controversial. In a physiologically and clinically relevant rat model of unilateral nephrectomy, we demonstrated that long-term oral administration of both cyclosporine and sirolimus at doses equivalent to the therapeutic levels used for postrenal transplant patients significantly affects testicular development and the hypothalamic-pituitary-gonadal axis accompanied by profound histological changes of testicular structures on both light and electron microscopic examinations. Spermatogenesis was also severely impaired as indicated by low total sperm counts along with reduction of sperm motility and increase in sperm abnormality after treatment with these agents, which may lead to male infertility. On the other hand, treatment with therapeutic dose of tacrolimus only induced mild reduction of sperm count without histological evidence of testicular injury. The current study clearly demonstrates that commonly used immunosuppressants have various impacts on male reproductive system even at therapeutic levels. Our data provide useful information for the assessment of male infertility in renal transplant recipients who wish to father children. Clinical trials to address these issues should be urged. © 2013 Yehui Chen et al.
KW - Cyclosporine/adverse effects
KW - Infertility, Male/chemically induced
KW - Sperm Count
KW - Kidney Transplantation/adverse effects
KW - Sirolimus/adverse effects
KW - Testis/drug effects
KW - Animals
KW - Spermatogenesis/drug effects
KW - Immunosuppressive Agents/adverse effects
KW - Humans
KW - Rats
KW - Male
UR - http://www.scopus.com/inward/record.url?scp=84880854570&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880854570&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/90574c83-7b95-3e83-81c2-3a329cf275a2/
U2 - 10.1155/2013/690382
DO - 10.1155/2013/690382
M3 - Article
C2 - 23936832
SN - 2314-6133
VL - 2013
JO - BioMed Research International
JF - BioMed Research International
M1 - 690382
ER -